Skip to content

Clinical trials

Phase 3 Coronary Disease trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Phase 3 Country / region: Netherlands Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20051
20061
20072
20082
20092
20112
20121
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche3
GlaxoSmithKline2
Pfizer2
R&D Cardiologie2
Abbott Medical Devices1
Amarin Pharma Inc.1
Amgen1
AstraZeneca1
Johns Hopkins University1
Kowa Research Europe1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease15
Coronary Artery Disease6
Cardiovascular Diseases4
Heart Diseases4
Atherosclerosis3
Coronary Stenosis3
Dyslipidemias3
Myocardial Ischemia3
Vascular Diseases3
Acute Coronary Syndrome2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.